ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,728.80
0.41%
US Tech 100
19,528.00
0.90%
Dow Jones
42,052.19
0.69%
Brent Oil
72.905
0.00%
Bitcoin
69,598.53
0.17%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSX

  6. Eupraxia Pharmaceuticals Inc (EPRX) Quote

Eupraxia Pharmaceuticals Inc

Eupraxia Pharmaceuticals Inc (EPRX)

Eupraxia Pharmaceuticals Inc
4.30
1.00
(30.30%)
Closed November 02 4:12PM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
4.30
Bid
4.26
Ask
4.50
Volume
293,083
3.47 Day's Range 5.10
3.07 52 Week Range 7.64
Market Cap
117.313M
Previous Close
3.30
Open
3.50
Last Trade
100
@
4.3
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
19,256
Shares Outstanding
27,282,000
Dividend Yield
-
PE Ratio
-4.16
Earnings Per Share (EPS)
-1.03
Revenue
-
Net Profit
-28.22M

About Eupraxia Pharmaceuticals Inc

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.eupraxiapharma.com
Headquarters
Victoria, British Columbia, Can
Founded
-
Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the Toronto Stock Exchange with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $3.30. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 3.07 to $ 7.64.

Eupraxia Pharmaceuticals currently has 27,282,000 shares outstanding. The market capitalization of Eupraxia Pharmaceuticals is $90.03 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -4.16.

Ask ADVFN Intelligence (AI)

EPRX Latest News

More News

Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million

Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million Canada NewsWire VICTORIA, BC, Oct. 31, 2024 VICTORIA, BC, Oct. 31, 2024 /CNW/ - Eupraxia...

October 31 2024
PR Newswire (Canada)

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024

Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024 Canada NewsWire VICTORIA, BC, Oct. 28, 2024 VICTORIA, BC, Oct. 28, 2024 /CNW/ - Eupraxia...

October 28 2024
PR Newswire (Canada)

Lancet Rheumatology Publishes Phase 2b Data on Eupraxia Pharmaceuticals' EP-104IAR for the Treatment of Knee Osteoarthritis

Lancet Rheumatology Publishes Phase 2b Data on Eupraxia Pharmaceuticals' EP-104IAR for the Treatment of Knee Osteoarthritis Canada NewsWire VICTORIA, BC, Oct. 15, 2024 Publication...

October 15 2024
PR Newswire (Canada)

Eupraxia Pharmaceuticals to Present at United European Gastroenterology Week 2024

Eupraxia Pharmaceuticals to Present at United European Gastroenterology Week 2024 Canada NewsWire VICTORIA, BC, Oct. 10, 2024 VICTORIA, BC, Oct. 10, 2024 /CNW/ - Eupraxia Pharmaceuticals Inc...

October 10 2024
PR Newswire (Canada)

Eupraxia Pharmaceuticals Strengthens Senior Management Team

Eupraxia Pharmaceuticals Strengthens Senior Management Team PR Newswire VICTORIA, BC, Oct. 2, 2024 VICTORIA, BC, Oct. 2, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or...

October 02 2024
PR Newswire (US)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.8825.7309941523.425.13.3417533.42164621CS
40.7521.12676056343.555.13.07248783.38000402CS
120.6718.45730027553.635.13.07192563.47011996CS
260.616.21621621623.75.13.07181583.61102337CS
52-0.97-18.40607210635.277.643.07294974.38152388CS
1562.1398.15668202762.179.10.8267174.1886225CS
260-3.45-44.51612903237.759.10.8245314.21323444CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EPRXEupraxia Pharmaceuticals Inc
$ 4.30
(30.30%)
293.08k
RAY.BStingray Group Inc
$ 7.59
(24.02%)
2.55k
NUMINuminus Wellness Inc
$ 0.03
(20.00%)
16.85k
AREAecon Group Inc
$ 27.51
(18.63%)
1.3M
RTGRTG Mining Inc
$ 0.04
(14.29%)
23.5k
VRTSVertiqal Studios Corporation
$ 0.01
(-33.33%)
8k
PPRPrairie Provident Resources Inc
$ 0.03
(-25.00%)
1.12M
FLNTFlint Corporation
$ 0.02
(-20.00%)
11.01k
AEGAegis Brands Inc
$ 0.36
(-14.29%)
26k
XMF.AM Split Corp
$ 0.40
(-12.09%)
10k
ACAir Canada
$ 21.50
(13.94%)
17.13M
VRNVeren Inc
$ 6.94
(-3.21%)
9.07M
ENBEnbridge Inc
$ 56.43
(0.34%)
8.64M
BTEBaytex Energy Corp
$ 4.08
(3.82%)
8.56M
MFCManulife Financial Corporation
$ 41.13
(1.13%)
6.67M

Discussion

View Full Feed
Pacha78 Pacha78 2 minutes ago
AS updated to 1.98B
Per OTCMarkets

https://www.otcmarkets.com/stock/NUGN/security
NUGN
MartinLutherKing MartinLutherKing 3 minutes ago
Nobel for MicroRNA Work: Recognising Basic Science, Open Research
S. Krishnaswamy | 02 Nov 2024
Science
International
Research into miRNAs may uncover new therapeutic strategies for conditions like cancer, cardiovascular disease, and neurodegenerative disorders.
ht
RNAZ
nyt nyt 6 minutes ago
And neither will go anywhere as it's obvious they are meritless from jumpstreet. Merely a thick fog to wade thru for all, whilst the raking in of your monies continues, unabated, for at least 4 more years. The emu of eGipped didn't get this far into this farce, by using silly, useless, worn out, uns
VPLM
MartinLutherKing MartinLutherKing 6 minutes ago
Cancer Research Takes a Leap Thanks to Nobel-Winning MicroRNA Discovery
The Nobel Prize-winning discovery of microRNA has reshaped our understanding of gene regulation. Learn what these tiny molecules mean for cancer research.
https://www.discovermagazine.com/the-sciences/cancer-resear
RNAZ
powerwalker powerwalker 7 minutes ago
Nunc est Bibendum

Steady, not sure I ever read why you selected this slogan: is it because you like "Happy Hour" or you are the Michelin Man?
AVXL
ksquared ksquared 8 minutes ago
Morning, cap.
Gutfeld would agree with the list.
Last night he declared the death of the LSM on The Five and his show.
We can only hope.
Here's to the new day and a round of clock resets.
FALL
JD400 JD400 8 minutes ago
Good Morning Miners

Good Morning 🌞
[yt]fF1lqEQFVUo[/yt]

MARKET ACTIVITY
TSX +98.29 (0.41%) 24,255.16
TSX Venture +2.52 (0.42%) 603.95
ASX 200 -41.20 (0.50%) 8,118.80
S&P 500 +23.35 (0.41%) 5,728.80
BMO Junior Gold Index
ASX
ksquared ksquared 11 minutes ago
Trump, Harris head to North Carolina in US election campaign's final weekend
By James Oliphant and Nandita Bose November 2, 2024 5:05 AM EDT Updated 2 hours ago
(TG he won't be in Ann Arbor. Not a good venue for him. JMO)

MILWAUKEE, Nov 2 (Reuters) - Democrat Kamala
rainmaker71 rainmaker71 12 minutes ago
Are you hearing might there be some additional surprise nuggets in the next announcement?
VDRM
JD400 JD400 13 minutes ago
Good Morning Miners

Good Morning 🌞
[yt]fF1lqEQFVUo[/yt]

MARKET ACTIVITY
TSX +98.29 (0.41%) 24,255.16
TSX Venture +2.52 (0.42%) 603.95
ASX 200 -41.20 (0.50%) 8,118.80
S&P 500 +23.35 (0.41%) 5,728.80
BMO Junior Gold Index
ASX
Capt Caveman Capt Caveman 13 minutes ago
98% short volume
percentage 11-1-24

marketwirenews.com

DBMM
DBMM
cojoboy cojoboy 15 minutes ago
Good morning bro...it's Saturday.. Time to sleep in.
IGPK
cojoboy cojoboy 16 minutes ago
Very true...
IGPK
Investor2014 Investor2014 19 minutes ago
I am about 17% optimistic. If that is your definition fraud, so be it.
AVXL
ksquared ksquared 21 minutes ago
Woke Wienies...
https://nypost.com/wp-content/uploads/sites/2/2024/11/Front-Page-11-02-2024_.jpg?resize=394,441&quality=90&strip=all&w=750
Hopeforthefuture3 Hopeforthefuture3 21 minutes ago
Jman4956, fo to the nwbo web site and look at the PR from May 28 2019 and it has some of the detail on the deal with cognate. I think there was also a sec filing on the deal. They did pay cognate $ (or shares) and per the PR dcvax direct was to re-start within 10 weeks
NWBO
Dyno89 Dyno89 23 minutes ago
Can you ask him why the hell he doesn't just go non audited for now and submit the standard otc fins to at least get pink current and off EM?

Clearly if they can't generate even 100k at this point 8 months later after fins were initially due for last year and still remain on EM, it's
ENZC RSPI
CanItBThisEZ2Make CanItBThisEZ2Make 28 minutes ago
BEST SELLERS RANK (BSR) IS 720 28 Estimated Sold on Amazon Since OCT 1 - 4TH Quarter 2024
https://investorshub.advfn.com/uimage/uploads/2024/4/24/cnxttVOS_5G_GIF.gif
https://www.amazon.com/Vos-RDGL5GX55-B-01-VOS-5G-Dongle/dp/B0C66KHZLP

NOTE: In theory, when BSR Value Dec
SRMX
Polymer Paul Polymer Paul 31 minutes ago
Opened the fortune cracker with my Chinese last night and it read....Be aware of the man who doesn't even own a TV ... Yet forever talks about oleds being everywhere and ubiquitous!
LWLG
MartinLutherKing MartinLutherKing 32 minutes ago
It’s hot on all the wires brother
https://www.newsclick.in/nobel-microrna-work-recognising-basic-science-open-research?amp
RNAZ

Your Recent History

TSX
EPRX
Eupraxia Pharmaceuticals
BIT
S29038
Societe Generale Effekten
BIT
UI900A
Unicredit Bank
LSE
0Q0J
Mitsubishi
NYSE
NREF-A
NexPoint Real Estate Fin...
BIT
P1MOO8
BNP Paribas Issuance
NYSE
KEYS
Keysight Technologies
NASDAQ
MHUA
Meihua International Med...
BIT
UC41KT
Unicredit Bank
BIT
UC5R46
Unicredit Bank
LSE
HGVE
Hsbc Icav Gl Go
AQSE
VUAG.GB
Vanguard Funds
USOTC
GAPJ
Golden Apple Oil and Gas (CE)
NYSE
DBRG
DigitalBridge
LSE
HANA
Hansa Investment
NYSE
EFC-B
Ellington Financial
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved